Skip to main content

Table 1 Patient characteristics at the baseline visit

From: Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs

Patients n = 356  
Female (%) 79.8%
Age (years) 59.9 ± 12.7
Disease duration (years) 11.5 ± 10.2
Rheumatoid factor positive(%) 59%
C-reactive protein (mg/dl) 2.1
Erythrocyte sedimentation rate (mm/hour) 25.9 ± 21.9
Swollen-joint count 28 2.1 ± 3.0
Tender-joint count 28 2.1 ± 3.8
Visual analogue scale pain (mm) 28.0 ± 22.4
Patient global assessment of disease activity (mm) 30.0 ± 23.3
Evaluator global assessment of disease activity (mm) 11.0 ± 13.7
Clinical disease activity index 8.3 ± 7.3
Simplified disease activity index 9.1 ± 7.7
Disease activity score 28 3.2 ± 1.2
Health-assessment questionnaire 0.81 ± 0.76
Euro QolL5D 0.77 ± 0.19
Physical component score SF-36 37.6 ± 11.3
Mental component score SF-36 48.0 ± 12.0
Patients currently employed (%) 26.5%
Activity impairment due to problem (%) 35.9 ± 26.7
Work time missed due to RA (%) 7.7 ± 24.5
Impairment while working due to problem (%) 27.8 ± 26.8
Overall work impairment due to RA (%) 2.7 ± 10.5
  1. Values reported as means ± standard deviation, unless indicated otherwise.